The possible $4bn cost to vaccine roll-out delay



The delay to the COVID-19 vaccine roll-out could cost the Government more than $4 billion and increase the likelihood of more lockdowns and restrictions.
The Government had initially set a roadmap to have 65% of people vaccinated by August, but this was now likely to be unachievable due to concerns about the AstraZeneca vaccine. Due to the risk of blood clots, it was recommended this specific jab was not given to those under-50, meaning Australia would have to wait for additional doses of the Pfizer jab which could take until Q4 2021 to arrive.
According to a report from the McKell Institute, in a best-case scenario, Australia would delay herd immunity by 116 days from the Government’s original estimate and cost $1.3 billion. However, in a worse scenario, it could be delayed by 353 days which would cost the Government $4.1 billion due to the increased risk of further lockdowns.
Executive director, Michael Buckland, said: “These delays will increase the chance of lockdown and the economic costs that come with them. It is vital that we are clear sighted about the cost and impact of Government’s action or inaction.
“Just as it was correct for the Government to measure the economic impact of state lockdowns, so too should the Government embrace the publication of clear information about the economic impact of its vaccination roll-out program.”
Recommended for you
An adviser has received a written reprimand from the Financial Services and Credit Panel after failing to meet his CPD requirements, the panel’s first action since June.
AMP has reported a 61 per cent rise in inflows to its platform, with net cash flow passing $1 billion for the quarter, but superannuation fell back into outflows.
Those large AFSLs are among the groups experiencing the most adviser growth, indicating they are ready to expand following a period of transition and stabilisation after the Hayne royal commission.
The industry can expect to see more partnerships in the retirement income space in the future, enabling firms to progress their innovation, according to a panel.